Health of Babies Born From IVF Versus IVM at 5 Years Old
Launched by MỸ ĐỨC HOSPITAL · Apr 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the health and development of children who were born through two different methods of assisted reproduction: In-vitro Fertilization (IVF) and In-vitro Maturation (IVM). The goal is to see if there are any differences in how these children develop by the time they are five years old. This study is particularly focused on helping women with a certain condition called high antral follicle count, which can affect fertility.
To participate in this study, children need to have been born from either IVF or IVM methods used in a previous research project. Parents must also agree to take part in the study. Unfortunately, if a child has passed away before reaching five years old, they cannot be included. Families who participate will help researchers gather important information about the long-term safety and outcomes of these fertility treatments, which could benefit future parents considering these options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All babies born following the In-vitro Maturation and In-vitro fertilization from our FM study (NCT03405701) participated in our previous follow-up study (NCT04296357)
- • Parents agree to participate in the study.
- Exclusion Criteria:
- • Babies died under or at 60 months
About Mỹ đức Hospital
Mỹ Đức Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong emphasis on ethical practices and patient safety, the hospital collaborates with reputable research organizations and healthcare professionals to conduct studies across various therapeutic areas. Committed to excellence in clinical research, Mỹ Đức Hospital leverages its state-of-the-art facilities and experienced staff to contribute valuable insights that enhance medical knowledge and treatment options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh City, Tan Binh, Vietnam
Patients applied
Trial Officials
Lan N Vuong, MD, PhD
Principal Investigator
Mỹ Đức Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported